ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Beijing Tong Ren Tang Chinese Medicine Co., Ltd. ?
1
High Management Efficiency with a high ROE of 19.94%
2
Company has very low debt and has enough cash to service the debt requirements
3
Healthy long term growth as Net Sales has grown by an annual rate of 28.67% and Operating profit at 36.57%
4
Flat results in Jun 25
- OPERATING CASH FLOW(Y) Lowest at HKD 335.28 MM
- INTEREST COVERAGE RATIO(Q) Lowest at 9,248.06
- PRE-TAX PROFIT(Q) Lowest at HKD 289.48 MM
5
With ROE of 12.40%, it has a Attractive valuation with a 1.88 Price to Book Value
- Over the past year, while the stock has generated a return of -12.34%, its profits have risen by 14.6% ; the PEG ratio of the company is 1
6
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -12.34% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Beijing Tong Ren Tang Chinese Medicine Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
28.67%
EBIT Growth (5y)
36.57%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.35
Tax Ratio
17.26%
Dividend Payout Ratio
58.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
86.34%
ROE (avg)
19.94%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.88
EV to EBIT
9.91
EV to EBITDA
9.81
EV to Capital Employed
2.55
EV to Sales
4.66
PEG Ratio
1.04
Dividend Yield
0.05%
ROCE (Latest)
25.75%
ROE (Latest)
12.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 4.44 times
-5What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at HKD 335.28 MM
INTEREST COVERAGE RATIO(Q)
Lowest at 9,248.06
PRE-TAX PROFIT(Q)
Lowest at HKD 289.48 MM
Here's what is working for Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Debtors Turnover Ratio
Highest at 4.44 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at HKD 48.05 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 48.05 MM has Grown at 6.28%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Beijing Tong Ren Tang Chinese Medicine Co., Ltd.
Interest Coverage Ratio
Lowest at 9,248.06
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Cash Flow
Lowest at HKD 335.28 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Pre-Tax Profit
Lowest at HKD 289.48 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
